Oct 12, 2026
77:71
For every 71 shares held, investors received 77. The price per share adjusted from $0.01 to $0.01.
The split itself did not change the total investment value.
Cynata Therapeutics Limited (ASX:CYP) operates in the Biotechnology industry.
Cynata Therapeutics Limited company overviewCynata Therapeutics Limited's most recent stock split was on October 12, 2026. It was a 77-for-71 forward split, so shareholders received 77 shares for every 71 they held.
Cynata Therapeutics Limited (ASX:CYP) has split its stock 3 times: a 21-for-19 split on March 30, 2012, a 1-for-20 reverse split on October 31, 2013, and a 77-for-71 split on October 12, 2026.
Cynata Therapeutics Limited has split its stock 3 times. This history records 3 splits between March 30, 2012 and October 12, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Cynata Therapeutics Limited's 77-for-71 split on October 12, 2026, every 71 shares became 77 shares.
Cynata Therapeutics Limited has not announced a new split in our records. Its most recent split was on October 12, 2026, less than a year ago. Companies announce splits in advance, and any new ASX:CYP split will appear on this page.
Already premium?